Your selection basket is empty.
Define a selection of ETFs which you would like to compare.
Add an ETF by clicking "Compare" on an ETF profile or by checkmarking an ETF in the ETF search.
Beijing Wantai Biological
ISIN CNE100004090
|WKN A2QK68
Market cap (in EUR)
6,379 m
Country
China
Sector
Healthcare
Dividend yield
0.70%
Overview
Description
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. engages in the research and development, production, and sale of in vitro diagnostic reagents and equipment, and vaccines. It operates through the In Vitro Diagnostic Reagents and Vaccines segments. The In Vitro Diagnostic Reagents segment covers human immunodeficiency virus and viral hepatitis reagents, and automatic tubular chemiluminescence immunoassay systems. The Vaccines segment offers recombinant hepatitis E, human papillomavirus, and freeze-dried live attenuated varicella vaccines. The company was founded on April 24, 1991 and is headquartered in Beijing, China.
Healthcare Healthcare Equipment Diagnostics and Drug Delivery Devices China
Financials
Key metrics
| Market capitalisation, EUR | 6,379 m |
| EPS, EUR | -0.03 |
| P/B ratio | 4.2 |
| P/E ratio | 780.4 |
| Dividend yield | 0.70% |
Income statement (2024)
| Revenue, EUR | 287 m |
| Net income, EUR | 14 m |
| Profit margin | 4.75% |
What ETF is Beijing Wantai Biological in?
There are 21 ETFs which contain Beijing Wantai Biological. All of these ETFs are listed in the table below. The ETF with the largest weighting of Beijing Wantai Biological is the Xtrackers Harvest CSI 300 UCITS ETF 1D.
Latest articles
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH. Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.